This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philippon, A.
Right arrow Articles by Jacoby, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philippon, A.
Right arrow Articles by Jacoby, G. A.

Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 1-11, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.1-11.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

MINIREVIEW

Plasmid-Determined AmpC-Type ß-Lactamases

Alain Philippon,1 Guillaume Arlet,2 and George A. Jacoby3*

Service de Bactériologie, Université Paris V—Hôpital Cochin,1 Service de Bactériologie, Hôpital Tenon, Paris, France,2 VA Medical Center, Bedford, and Lahey Clinic, Burlington, Massachusetts3


arrow
INTRODUCTION
 
The predominant mechanism for resistance to ß-lactam antibiotics in gram-negative bacteria is the synthesis of ß-lactamase. To meet this challenge, ß-lactams with greater ß-lactamase stability, including cephalosporins, carbapenems, and monobactams, were introduced in the 1980s. Resistance appeared initially in organisms such as Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, and Pseudomonas aeruginosa that could, by mutation, overproduce their chromosomal AmpC (also termed class C or group 1) ß-lactamase, thus providing resistance to both oxyimino- and 7-{alpha}-methoxy-cephalosporins and monobactams (74).

Later, resistance appeared in bacterial species that lack an inducible AmpC enzyme, such as Klebsiella pneumoniae, Escherichia coli, Salmonella spp., and Proteus mirabilis, and this resistance was found to be mediated by plasmids encoding extended-spectrum ß-lactamases (ESBLs), which are enzymes that arose by mutations in TEM or SHV ß-lactamases of more limited hydrolytic capacity (39, 40, 68). Such resistance included oxyimino-cephalosporins and monobactams but not 7-{alpha}-methoxy-cephalosporins and was blocked by clavulanate, sulbactam, or tazobactam, which are inhibitors that are generally ineffective against class C enzymes (49, 75).

With continuing use of 7-{alpha}-methoxy-cephalosporins (cefoxitin and cefotetan) and the clinical introduction of ß-lactamase inhibitor combinations (clavulanate with amoxicillin or ticarcillin, sulbactam with ampicillin, and tazobactam with piperacillin), plasmids encoding class C ß-lactamases appeared (56). Like their counterpart on the chromosome, such enzymes provided a broader spectrum of resistance than ESBLs and were not blocked by commercially available inhibitors.

Furthermore, in a strain with decreased outer membrane permeability such enzymes can provide resistance to carbapenems as well, as has been observed with clinical isolates of K. pneumoniae during an outbreak in New York (13) and in individual isolates of E. coli in the United Kingdom (78) and of K. pneumoniae in Sweden (17).


arrow
HISTORY
 
AmpC ß-lactamases, demonstrated or presumed to be chromosomally mediated, have been described in Acinetobacter spp., Aeromonas spp., Chromobacterium violaceum, C. freundii, Enterobacter spp., E. coli, Hafnia alvei, Lysobacter lactamgenus, Morganella morganii, Ochrobactrum anthropi, Proteus rettgeri, Providencia stuartii, P. aeruginosa, Psychrobacter immobilis, Rhodobacter sphaeroides, S. marcescens, and Yersinia enterocolitica. In many genera, AmpC is inducible via a system involving ampD, ampG, ampR, and intermediates in peptidoglycan recycling (38, 86). The ampC gene of E. coli is normally expressed at a low level, regulated by a growth rate-dependent attenuation mechanism (42) but not by induction, since ampR is missing (35). In Shigella flexneri and Shigella dysenteriae, ampC is included in a large deletion (55). An ampC locus appears on the genetic map of Salmonella (76), but the evidence for its existence was indirect and its presence has not been confirmed in the sequenced genomes of Salmonella enterica serotypes Typhimurium or Paratyphi (57), so that Salmonella is considered to be AmpC- (56). A chromosomal ampC gene is also lacking in Klebsiella spp. (57) and P. mirabilis.

In 1976, Bobrowski et al. described a plasmid-mediated ß-lactamase indistinguishable from the AmpC enzyme of E. coli in a strain of P. mirabilis (11). Unfortunately, the original plasmid was lost, there was some doubt about the transfer experiments, and molecular studies were not done. In 1982, Levesque et al. reported a plasmid-mediated cephalosporinase in Achromobacter spp. (48). Regrettably, the original strain was lost, the ß-lactamase gene was not sequenced, and in retrospect the biochemical properties of the enzyme resembled those of a group 2b broad-spectrum enzyme rather than of a group 1 cephalosporinase. In 1983, Knothe et al. reported the transfer of cefoxitin resistance from S. marcescens to Proteus or Salmonella spp., but resistance segregated on transfer to E. coli and no biochemical or molecular studies were done (44).

In 1989, Bauernfeind et al. described a K. pneumoniae isolate from South Korea that could transfer resistance to cefoxitin and cefotetan as well as to penicillins, oxyimino-cephalosporins, and monobactams to E. coli (6). The enzyme, termed CMY-1 for its cephamycinase activity, had an isoelectric point (pI) of 8.0 and was more sensitive to inhibition by sulbactam than by clavulanate or tazobactam, suggesting that it might be a class C enzyme. However, the first proof that a class C ß-lactamase had been captured on a plasmid was provided by Papanicolaou et al., who described transmissible resistance to {alpha}-methoxy- and oxyimino-ß-lactams mediated by an enzyme (MIR-1) with the biochemical properties of a class 1 ß-lactamase and showed that part of the MIR-1 gene was 90% identical to the ampC gene of E. cloacae (65).

Subsequently, plasmid-mediated class C ß-lactamases have been discovered worldwide (Table 1). They have been named with inconsistency typical of ß-lactamase nomenclature according to the resistance produced to cephamycins (CMY), cefoxitin (FOX), and moxalactam (MOX) or latamoxef (LAT), to the type of ß-lactamase, such as AmpC type (ACT) or Ambler class C (ACC), and to the site of discovery, such as the Miriam Hospital in Providence, R.I. (MIR-1) or Dhahran hospital in Saudi Arabia (DHA). BIL-1 was even named after the patient (Bilal) who provided the original sample (D. J. Payne, personal communication).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Chronology of discovery of AmpC plasmid-encoded ß-lactamasesa

Increasingly, a demonstration of enzyme uniqueness relies on nucleotide sequencing, a sometimes imperfect technique. Barlow and Hall (M. Barlow and B. G. Hall, submitted for publication) recently reanalyzed several plasmid-mediated AmpC genes and concluded that the amino acid sequences of CMY-2, BIL-1, and LAT-2 were identical, as were LAT-1 and LAT-4 and also LAT-3 and CMY-6. In the text and tables below, the originally published names have been retained, with apparent identities in parentheses, such as BIL-1 (CMY-2).


arrow
EPIDEMIOLOGICAL FEATURES
 
As shown in Table 1, plasmid-mediated class C ß-lactamases have been discovered most frequently in isolates of K. pneumoniae and also in other naturally AmpC- species such as K. oxytoca, Salmonella, and P. mirabilis. Some enzymes have been found in E. coli, although this species can also increase production of its normally weakly expressed chromosomal AmpC enzyme by gene duplication or mutation in the ampC promoter or attenuator with consequent enhanced gene expression (18, 62). In Greece, plasmid-mediated LAT-2 (CMY-2) has been found in clinical isolates of Enterobacter aerogenes simultaneously with its appearance in clinical strains of K. pneumoniae and E. coli (28), and in France plasmid-mediated ACC-1 has been found in both E. coli and P. mirabilis isolates obtained from the same urine sample (30). In the United States, ceftriaxone-resistant Salmonella have begun to appear that owe their resistance to plasmid-mediated CMY-2 ß-lactamase. Between 1996 and 1998, 13 ceftriaxone-resistant Salmonella strains were isolated from symptomatic patients in eight different states (22). Several Salmonella serotypes were involved. Such strains have been isolated from cattle and pigs (87). One 12-year old boy living in Nebraska was infected with a ceftriaxone-resistant strain identical to S. enterica serotype Typhimurium strains isolated from his father’s infected calves (23).

A striking feature is the global distribution of strains producing plasmid-determined cephalosporinases. They have been found in Africa (Algeria, Tunisia), Asia (India, Japan, Pakistan, South Korea), Europe (France, Germany, Greece, Italy, Sweden, United Kingdom), the Middle East (Saudi Arabia), North America (United States), and South and Central America (Argentina, Guatemala) (Table 1). Just as with strains producing ESBLs such as SHV-2 or SHV-5 (77), travel and transfer of patients has allowed the importation of BIL-1 (CMY-2) from Pakistan to the United Kingdom (66), strains with BIL-1-like enzymes from the Indian subcontinent to London (59), several CMY types (CMY-2, CMY-6, CMY-7) from Punjab (India) to London (unpublished results), CMY-2 from Algeria to France (46), CMY-4 from India to Sweden (17), FOX-2 from Guatemala to Germany (10), ACC-1 from Tunisia to France (30, 60), and MOX-2 from Greece to France (S. Boyer-Mariotte, L. Raskine, B. Hanau, A. Philippon, M. M. Sanson-LePors, and G. Arlet, Abstr. 38th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C-7, 1998). CMY-2 is the most prevalent of the plasmid-mediated AmpC enzymes and the most widely distributed geographically, having been reported in Algeria, France, Germany, Greece, India, Pakistan, Taiwan, Turkey, the United Kingdom, and the United States (5).

Except for Salmonella strains and occasional K. pneumoniae isolates (43), most strains producing plasmid-determined AmpC enzymes have been isolated from patients after several days in the hospital. Affected patients have often had prolonged stays in intensive care units. Some patients had one or more surgical procedures (65), an underlying disease such as leukemia (78) or cancer (27, 36, 59), or were immunocompromised after liver or kidney transplantation (59). Sources of organisms included cultures of urine (about 50% of isolates), blood, wounds, sputum, or stool. Some isolates were recovered in mixed cultures with other potential pathogens. A majority of the patients had been treated with ß-lactam antibiotics including cefoxitin, moxalactam, cefmetazole, cefotetan, or imipenem (13, 31, 36, 65). Many strains with plasmid-determined AmpC enzymes also produce TEM-1, TEM-2, or even an ESBL, such as SHV-5 (28, 29, 59).

As already observed for ESBL-producing K. pneumoniae organisms (15, 61, 72), AmpC-producing nosocomial isolates can be responsible for outbreaks, for example, MIR-1 (11 patients) (65), a BIL-1(CMY-2)-like enzyme (5 patients) (59), ACC-1 (13 patients) (60), and ACT-1 (17 patients) (13).


arrow
SUSCEPTIBILITY PATTERNS
 
Table 2 illustrates in vitro susceptibilities for E. coli transconjugants or transformants producing plasmid-mediated AmpC ß-lactamases. Some of the MICs for what ought to be similar enzymes differ by more than can be attributed to experimental variation (e.g., LAT-1 and LAT-4 with cefotaxime, ceftazidime, or aztreonam) and may have resulted from differences in host E. coli strains. Strains with plasmid-mediated AmpC enzymes were consistently resistant to aminopenicillins (ampicillin or amoxicillin), carboxypenicillins (carbenicillin or ticarcillin), and ureidopenicillins (piperacillin) and, among the penicillins, these strains were susceptible only to amdinocillin or temocillin. The enzymes provided resistance to cephalosporins in the oxyimino group (ceftazidime, cefotaxime, ceftriaxone, ceftizoxime, cefuroxime) and the 7-{alpha}-methoxy group (cefoxitin, cefotetan, cefmetazole, moxalactam). MICs were usually higher for ceftazidime than for cefotaxime and for cefoxitin than for cefotetan. The enzymes were also active against the monobactam aztreonam, although for some strains aztreonam MICs were in the susceptible range. Susceptibility to cefepime or cefpirome was little affected and was unchanged for carbapenems (imipenem, meropenem).


View this table:
[in this window]
[in a new window]
  		TABLE 2. In vitro susceptibilities (MIC) of E. coli derivatives producing plasmid-encoded AmpC ß-lactamase

Alterations in antibiotic access to the enzyme can markedly change the susceptibility profile. With loss of outer membrane porin channels, K. pneumoniae strains carrying plasmids determining AmpC enzymes can have imipenem MICs as high as 64 µg/ml and meropenem MICs of 16 µg/ml (53). In such strains, MICs of cefepime and cefpirome become inoculum dependent, and at inocula of 107/ml MICs can exceed 256 µg/ml (53). Clinical isolates of K. pneumoniae and E. coli with imipenem MICs from 16 to 64 µg/ml through porin loss and carriage of ACT-1 (13) or CMY-4 (17, 78) have already been reported and are a cause for concern.

The effects of ß-lactamase inhibitors on susceptibility is summarized in Table 3. Although commercially available inhibitors, especially sulbactam, caused a modest reduction in MICs of cefoxitin, E. coli derivatives with plasmid-mediated AmpC enzymes were not susceptible to inhibitor combinations, with the possible exception of piperacillin-tazobactam. Resistance was, however, blocked by BRL 42715 (7, 19, 53), Ro 47-8284 (7), Ro 48-1256 (50), or Ro 48-1220 (81).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Effect of ß-lactamase inhibitors (MIC) on E. coli derivatives producing plasmid-mediated AmpC ß-lactamases


arrow
DETECTION
 
In bacterial species without an inducible AmpC-type ß-lactamase, appearance of a susceptibility pattern typical of an Enterobacter or C. freundii isolate that overproduces its chromosomal ß-lactamase is highly suggestive of a plasmid-encoded AmpC-type enzyme (56, 67). Unfortunately, other mechanisms can produce a similar resistance phenotype. In E. coli hyperproduction of chromosomal AmpC together with OmpF porin loss (52), or in K. pneumoniae porin deficiency alone (33), can give cephamycin and oxyimino-ß-lactam resistance. Furthermore, not all strains with plasmid-mediated AmpC enzymes meet the NCCLS criteria for resistance to cephamycins and oxyimino-cephalosporins. For example, E. coli with ACC-1 can be resistant to ceftazidime but not cefoxitin or cefotetan, while a strain with DHA-2 was intermediate in resistance to cefoxitin but susceptible to cefotaxime or ceftazidime (Table 2). Suspected isolates can be studied further for cephamycin hydrolysis with the three-dimensional test (20, 80) or the Masuda bioassay (65) and for ß-lactamase inhibitor effects. Unfortunately, inhibitors (BRL 42715, Ro 47-8284, Ro 48-1220, Ro 48-1256) that are active against AmpC enzymes are not readily available, but cloxacillin (69) or cefoxitin (65) have been used to block AmpC activity selectively after isoelectric focusing. Lack of inhibition of activity against oxyimino-ß-lactams or cephamycins by clavulanate is indirect evidence for the presence of an AmpC enzyme, but some AmpC enzymes are unusually susceptible to inhibition by tazobactam (1). A reference laboratory is needed for ß-lactamase isoelectric focusing or gene localization. Detecting a plasmid-mediated AmpC enzyme in a strain with a native inducible ß-lactamase or a coexisting ESBL is even more challenging.

Given the difficulty in detecting plasmid-mediated AmpC ß-lactamases, their prevalence is currently likely to be underestimated. Coudron et al. studied 1,286 consecutive, nonrepeat isolates from a single VA Medical Center collected between 1995 and 1997 and estimated that 1.6% of E. coli isolates, 1.1% of K. pneumoniae isolates, and 0.4% of P. mirabilis isolates were cefoxitin-resistant AmpC ß-lactamase producers, mostly via transmissible plasmids (20).


arrow
ENZYMATIC PROPERTIES
 
Plasmid-mediated AmpC-type ß-lactamases have pIs between 6.4 and 9.4 (Table 1). Several of the FOX-type enzymes show multiple satellite bands (31). In clinical isolates containing several ß-lactamases, AmpC enzymes can be identified after isoelectric focusing by differential inhibition of nitrocefin reactivity with 5 mg of cefoxitin/ml (65) or detection of cefoxitin hydrolysis by bioassay (10). A few plasmids carry ampR as well as ampC genes and are inducible (DHA-1 and DHA-2) (3, 24), but most plasmid-mediated ampC genes are expressed constitutively, for example, MIR-1, even in the presence of a complete system for induction (41).

The apparent molecular size of the mature plasmid-mediated AmpC ß-lactamases vary from 38 to 42 kDa with 378 (3), 381 (8, 29, 41), 382 (10, 37), or 386 (7) amino acid residues. Kinetic properties were characteristic of chromosomal AmpC enzymes with relative Vmax values generally 10-fold or more greater for cephalothin and cephaloridine than for ampicillin and penicillin, greater activity with penicillin than with ampicillin, and low hydrolysis rates for oxyimino- or {alpha}-methoxy-compounds (Table 4). On the other hand, Km values for cefoxitin, cefotetan, cefotaxime, moxalactam, or aztreonam were generally less than those for penicillin or ampicillin and much lower than the Km values for cephaloridine, cephalothin, or cefepime (Table 5).


View this table:
[in this window]
[in a new window]
  		TABLE 4. Substrate profile (Vmax relative to cephaloridine) of plasmid-determined AmpC ß-lactamases


View this table:
[in this window]
[in a new window]
  		TABLE 5. Affinity constants (Km) of plasmid-encoded AmpC ß-lactamases

As is typical of group 1 cephalosporinases (16), plasmid-mediated AmpC enzymes were inhibited by low concentrations of aztreonam, cefoxitin, or cloxacillin and only by high concentrations of clavulanate (Table 6). Sulbactam and particularly tazobactam were more effective inhibitors but were an order of magnitude less potent than Ro 48-1220.


View this table:
[in this window]
[in a new window]
  		TABLE 6. Inhibition profiles of plasmid-determined AmpC ß-lactamases

The amino acid sequence of the enzymes revealed an active-site serine in the motif Ser-X-X-Lys (where X is any amino acid) at residues 64 to 67 of the mature protein. A Lys-Ser/Thr-Gly motif has been found at residues 315 to 317 and plays an essential role in forming the tertiary structure of the active site. A tyrosine residue at position 150 forms part of the class C-typical motif Tyr-X-Asn and is also important (but not essential) for catalysis of ß-lactam hydrolysis (21, 64)

A dendrogram of chromosomal and plasmid-encoded AmpC enzymes (Fig. 1) demonstrates the diversity of chromosomal AmpC genes and the close relationship of some plasmid-mediated enzymes to chromosomal enzymes of particular organisms. The plasmid-mediated enzymes can be divided into five or six clusters: the C. freundii group with LAT types and certain CMY types, the Enterobacter group with MIR-1 and ACT-1, the M. morganii group with DHA-1 and DHA-2, the H. alvei group represented by ACC-1, and the Aeromonas group with MOX-, FOX-, and other CMY-type enzymes. The relationship between plasmid-encoded enzymes and certain chromosomal ß-lactamases is very close: there is 100% amino acid homology within the M. morganii and H. alvei groups and more than 94% homology within the C. freundii group. ACT-1 and MIR-1 share 91.4% amino acid identity with each other but only 85 to 87% identity with most E. cloacae AmpC enzymes. However, the enzyme from E. cloacae strain GN7471 (47) has 91.1% identity to ACT-1 and MIR-1, and an environmental strain of Enterobacter was 98% identical (M. Rottman and G. Arlet, personal communication), so that origin from some Enterobacter species is likely. FOX enzymes have 95% or more sequence identity within the group, and CMY-1, CMY-8, and CMY-9 are more than 97% identical, but either group has only about 74% identity with the available Aeromonas sobria AmpC sequences, which in turn differ from each other by fully 25%. The AmpC sequence of P. aeruginosa is even more distant, so the origin of these enzymes remains uncertain.



View larger version (25K):
[in this window]
[in a new window]
  		FIG. 1. Dendrogram for chromosomal and plasmid-encoded AmpC ß-lactamases, calculated by Clustal X (34) and the neighbor-joining method (73). Branch lengths are proportional to the number of amino acid exchanges. GenBank accession numbers for blaAmpC can be found at http://www.rochester.edu/College/BIO/labs/HallLab/AmpC_Phylo.html

Unlike ESBLs, which differ from their parent enzymes by amino acid substitutions that alter the properties of the active site (45), remodeling seems not to be necessary for the success of a plasmid-mediated AmpC enzyme. M. Barlow and B. G. Hall (submitted) found that chromosomal ampC genes from C. freundii strains isolated in the 1920s were just as effective in providing ß-lactam resistance as plasmid-mediated ampC alleles such as CMY-2 or LAT-3 when all were cloned into a common vector in a common E. coli host. Nonetheless, once a blaAmpC gene is plasmid-borne further evolution may occur. For example, a naturally occurring Asn->Ile substitution at position 346 in CMY-1 has been reported to increase the ceftazidime MIC for a strain with the variant enzyme by four- to eightfold (A. Bauernfeind, I. Schneider, D. Meyer, R. Jungwirth, Y. Chong, and K. Lee, Abstr. 37th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C-203, 1997). It is likely that in time other such changes will be observed, since a variety of genetic changes can improve the activity of the chromosomal AmpC enzyme of E. cloacae to particular substrates, such as activity toward cefuroxime and ceftazidime with a tandem duplication of three amino acids at positions 208 to 210 (63) or toward cefepime and cefpirome with an amino acid substitution at position 318 (58) or a deletion of six amino acids at residues 289 to 294 (4).


arrow
GENETIC FEATURES
 
Genes for the AmpC enzymes have been located on plasmids of sizes varying from 7 to 180 kb (37, 78). A few of the plasmids have not been self-transmissible but are transferable by transformation (65, 78, 89) or mobilization (28, 29, 82, 83). Plasmids encoding AmpC enzymes often carry multiple other resistances, including resistance to aminoglycosides, chloramphenicol, sulfonamide, tetracycline, trimethoprim, or mercuric ion (9, 10, 13, 65, 78). A plasmid encoding a FOX-type enzyme even carried a gene for fluoroquinolone resistance (54). Clinical isolates often produce other ß-lactamases in addition to an AmpC enzyme. The bla genes may be on different plasmids, but often they coexist on the same plasmid. For example, the gene for ACT-1 was found in clinical isolates along with a pI 5.6 ß-lactamase consistent with TEM-10 or TEM-26 and a pI 7.6 enzyme consistent with SHV-1, and on cloning the ACT-1 gene was found in a 15-kb cluster with genes for a ß-lactamase of pI 5.4, presumably TEM-1, and pI 7.0, possibly another SHV-type enzyme (13). Furthermore, an ACT-1 probe hybridized to chromosomal DNA of these clinical strains, implying mobility of the gene by carriage on a transposon. Indirect evidence suggests that CMY-3 and CMY-4 could be transposon-mediated as well: CMY-3 because its gene is located on the chromosome of a species (P. mirabilis) lacking a native AmpC gene (14), and CMY-4 because in E. coli clinical isolates from London a CMY-4 probe hybridized to both 7-kb and 45-kb plasmids, a dual location that could be explained by transposability (78). The MIR-1 gene is located near a sequence closely related to an insertion sequence transposase, but direct attempts to demonstrate transposability of MIR-1 or BIL-1 (CMY-2) have not been successful (25, 41).

The C. freundii-type blaCMY-5 gene has been mapped in plasmid pTKH11 to be adjacent to the blc and sugE genes found downstream from ampC on the C. freundii chromosome (89). The ampR gene upstream from ampC on the chromosome is missing and its place has been taken by a putative insertion element which could have been involved in gene capture. So far as they have been sequenced, other plasmids encoding C. freundii-type AmpC enzymes have a similar organization (Fig. 2), suggesting a direct derivation from the C. freundii chromosome with subsequent accumulation of mutations in the ampC gene to produce the present array of CMY- and LAT-type enzymes, a conclusion also supported by phylogenetic analysis (M. Barlow and B. G. Hall, submitted).



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 2. Comparative genetic organization of plasmid-encoded ampC genes related to the chromosomal ß-lactamase gene of C. freundii. Adjacent nucleotide homology is that available for each gene and may be more extensive if carried further.

Many resistance genes, including those for Ambler class A, B, and D ß-lactamases, are located in gene cassettes with a downstream 59-base element that acts as a specific recombination site for incorporation into integrons (32). Analysis of published sequences indicates that AmpC genes found on plasmids are not linked to 59-base elements. The DHA-1 structural and regulatory genes on plasmid pSAL-1, however, are present in an integron (Fig. 3) which includes a site-specific integrase, two copies of qacE{Delta}1sulI, an aadA2 gene for aminoglycoside resistance with its downstream 59-base element, and ORF341, a postulated recombinase (84). The genetic organization of this integron is similar to In6 and In7 found in plasmids pSa and pDGO100, which lack bla genes (79). ampC and ampR genes from the chromosome of M. morganii (2, 70) thus appear to have inserted into a complex sulI-type integron. Since no downstream 59-base element remains, either it was deleted or integration involved another mechanism. Verdet et al. identified a 50-bp sequence near blaDHA-1 that is present also in In6 and In7. A virtually identical sequence occurs near genes for FOX-4, CMY-1, CMY-8, and MOX-1 (Fig. 4). Such a sequence could represent a recombination site different from the 59-base element. Further study of the structure of plasmids carrying ampC genes is likely to reveal additional tricks used by bacteria to mobilize genes for dissemination.



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 3. Structure of the integron coding for DHA-1 ß-lactamase in pSAL-1 and its relationship to genes on the chromosome of M. morganii.



View larger version (47K):
[in this window]
[in a new window]
  		FIG. 4. Comparison of the sequence between common regions of In7, In6, pSAL-1 (DHA-1), pROT (DHA-1), pGC-2 (FOX-4), pMVP-1 (CMY-1), pKPW142 (CMY-8), and pRMOX-1 (MOX-1).


arrow
CONCLUSIONS
 
Among gram-negative bacteria, the emergence of resistance to expanded-spectrum cephalosporins has been a major concern, initially in a limited number of bacterial species (E. cloacae, C. freundii, S. marcescens, and P. aeruginosa) that could mutate to hyperproduce their chromosomal class C ß-lactamase. A few years later, resistance appeared in bacterial species not naturally producing AmpC enzymes (K. pneumoniae, Salmonella spp., P. mirabilis) due to the production of TEM- or SHV-type ESBLs. Characteristically, such resistance has included oxyimino- but not 7-{alpha}-methoxy-cephalosporins, has been blocked by inhibitors such as clavulanate, sulbactam, or tazobactam, and did not involve carbapenems. Plasmid-mediated AmpC ß-lactamases represent a new threat since they confer resistance to 7-{alpha}-methoxy-cephalosporins such as cefoxitin or cefotetan, are not affected by commercially available ß-lactamase inhibitors, and can, in strains with loss of outer membrane porins, provide resistance to carbapenems. This resistance mechanism has been found around the world, can cause nosocomial outbreaks, appears to be increasing in prevalence, and merits further study to define the best options for detection and treatment.


arrow
ADDENDUM
 
The sequence of ORF341 has recently been revised, extending the open reading frame to 1,541 nucleotides that encode a protein of 513 amino acids; this sequence has been renamed ORF 513 (GenBank accession no. L06418).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805. Phone: (781) 744-8608. Fax: (781) 744-1264. E-mail: george.a.jacoby{at}lahey.org. Back


arrow
REFERENCES
 
    1
  1. Babini, G. S., F. Danel, S. D. Munro, P. A. Micklesen, and D. M. Livermore. 1998. Unusual tazobactam-sensitive AmpC ß-lactamase from two Escherichia coli isolates. J. Antimicrob. Chemother. 41:115–118.[Abstract/Free Full Text]
    2. 2
  2. Barnaud, G., G. Arlet, C. Danglot, and A. Philippon. 1997. Cloning and sequencing of the gene encoding the AmpC ß-lactamase of Morganella morganii. FEMS Microbiol. Lett. 148:15–20.[Medline]
    3. 3
  3. Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible ß-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352–2358.[Abstract/Free Full Text]
    4. 4
  4. Barnaud, G., R. Labia, L. Raskine, M. J. Sanson-Le Pors, A. Philippon, and G. Arlet. 2001. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195:185–190.[CrossRef][Medline]
    5. 5
  5. Bauernfeind, A., Y. Chong, and K. Lee. 1998. Plasmid-encoded AmpC ß-lactamases: how far have we gone 10 years after the discovery. Yonsei Med. J. 39:520–525.[Medline]
    6. 6
  6. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad spectrum ß-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316–321.[CrossRef][Medline]
    7. 7
  7. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC ß-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924–1931.[Abstract/Free Full Text]
    8. 8
  8. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Giamarellou. 1996. Characterization of the plasmidic ß-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221–224.[Abstract]
    9. 9
  9. Bauernfeind, A., I. Stemplinger, R. Jungwirth, R. Wilhelm, and Y. Chong. 1996. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other ß-lactamase genes. Antimicrob. Agents Chemother. 40:1926–1930.[Abstract]
    10. 10
  10. Bauernfeind, A., S. Wagner, R. Jungwirth, I. Schneider, and D. Meyer. 1997. A novel class C ß-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob. Agents Chemother. 41:2041–2046.[Abstract]
    11. 11
  11. Bobrowski, M. M., M. Matthew, P. T. Barth, N. Datta, N. J. Grinter, A. E. Jacob, P. Kontomichalou, J. W. Dale, and J. T. Smith. 1976. Plasmid-determined ß-lactamase indistinguishable from the chromosomal ß-lactamase of Escherichia coli. J. Bacteriol. 125:149–157.[Abstract/Free Full Text]
    12. 12
  12. Bou, G., A. Oliver, M. Ojeda, C. Monzón, and J. Martínez-Beltran. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated ß-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549–2553.[Abstract/Free Full Text]
    13. 13
  13. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC ß-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563–569.[Abstract]
    14. 14
  14. Bret, L., C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia, and J. Sirot. 1998. Chromosomally encoded ampC-type ß-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1110–1114.[Abstract/Free Full Text]
    15. 15
  15. Brun-Buisson, C., P. Legrand, A. Philippon, F. Montravers, M. Ansquer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302–306.
    16. 16
  16. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for ß-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211–1233.[Medline]
    17. 17
  17. Cao, V. T., G. Arlet, B. M. Ericsson, A. Tammelin, P. Courvalin, and T. Lambert. 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46:895–900.[Abstract/Free Full Text]
    18. 18
  18. Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 45:783–788.[Abstract/Free Full Text]
    19. 19
  19. Coleman, K., D. R. Griffin, J. W. Page, and P. A. Upshon. 1989. In vitro evaluation of BRL 42715, a novel ß-lactamase inhibitor. Antimicrob. Agents Chemother. 33:1580–1587.[Abstract/Free Full Text]
    20. 20
  20. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC ß-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans’ Medical Center. J. Clin. Microbiol. 38:1791–1796.[Abstract/Free Full Text]
    21. 21
  21. Dubus, A., S. Normarck, M. Kania, and M. G. P. Page. 1994. The role of tyrosine 150 in catalysis of ß-lactam hydrolysis by AmpC ß-lactamase from Escherichia coli investigated by site-directed mutagenesis. Biochemistry 33:8577–8586.[CrossRef][Medline]
    22. 22
  22. Dunne, E. F., P. D. Fey, P. Kludt, R. Reporter, F. Mostashari, P. Shillam, J. Wicklund, C. Miller, B. Holland, K. Stamey, T. J. Barrett, J. K. Rasheed, F. C. Tenover, E. M. Ribot, and F. J. Angulo. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC ß-lactamase. JAMA 284:3151–3156.[Abstract/Free Full Text]
    23. 23
  23. Fey, P. D., T. J. Safranek, M. E. Rupp, E. F. Dunne, E. I. P. C. Ribot, P. A. Bradford, F. J. Angulo, and S. H. Hinrichs. 2000. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342:1242–1249.[Abstract/Free Full Text]
    24. 24
  24. Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207–210.[Abstract/Free Full Text]
    25. 25
  25. Fosberry, A. P., D. J. Payne, E. J. Lawlor, and J. E. Hodgson. 1994. Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C ß-lactamase in Escherichia coli BS. Antimicrob. Agents Chemother. 38:1182–1185.[Abstract/Free Full Text]
    26. 26
  26. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable ß-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85–87.[Abstract/Free Full Text]
    27. 27
  27. Gazouli, M., M. E. Kaufmann, E. Tzelepi, H. Dimopoulou, O. Paniara, and L. S. Tzouvelekis. 1997. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J. Clin. Microbiol. 35:508–510.[Abstract]
    28. 28
  28. Gazouli, M., L. S. Tzouvelekis, E. Prinarakis, V. Miriagou, and E. Tzelepi. 1996. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 ß-lactamase (LAT-2). Antimicrob. Agents Chemother. 40:1736–1740.[Abstract]
    29. 29
  29. Gazouli, M., L. S. Tzouvelekis, A. C. Vatopoulos, and E. Tzelepi. 1998. Transferable class C ß-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC ß- lactamase. J. Antimicrob. Chemother. 42:419–425.[Abstract/Free Full Text]
    30. 30
  30. Girlich, D., A. Karim, C. Spicq, and P. Nordmann. 2000. Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli. Eur. J. Clin. Microbiol. Infect. Dis. 19:893–895.[CrossRef][Medline]
    31. 31
  31. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated ß-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150–2157.[Abstract/Free Full Text]
    32. 32
  32. Hall, R. M., and C. M. Collis. 1998. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist. Updates 1:109–119.
    33. 33
  33. Hernández-Allés, S., M. C. Conejo, A. Pascual, J. M. Tomás, V. J. Benedí, and L. Martínez-Martínez. 2000. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46:273–277.[Abstract/Free Full Text]
    34. 34
  34. Higgins, D. G., A. J. Bleasby, and R. Fuchs. 1992. CLUSTAL V: improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:189–191.[Abstract/Free Full Text]
    35. 35
  35. Honoré, N., M. H. Nicolas, and S. T. Cole. 1986. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J. 5:3709–3714.[Medline]
    36. 36
  36. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato. 1993. Plasmid-mediated AmpC-type ß-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum ß-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984–990.[Abstract/Free Full Text]
    37. 37
  37. Horii, T., Y. Arakawa, M. Ohta, T. Sugiyama, R. Wacharotayankun, H. Ito, and N. Kato. 1994. Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type ß-lactamase. Gene 139:93–98.[CrossRef][Medline]
    38. 38
  38. Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible ß-lactam resistance in gram-negative bacteria. Cell 88:823–832.[CrossRef][Medline]
    39. 39
  39. Jacoby, G. A. 1994. Genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):2–11.[CrossRef]
    40. 40
  40. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum ß-lactamases. Antimicrob. Agents Chemother. 35:1697–1704.[Free Full Text]
    41. 41
  41. Jacoby, G. A., and J. Tran. 1999. Sequence of the MIR-1 ß-lactamase gene. Antimicrob. Agents Chemother. 43:1759–1760.[Abstract/Free Full Text]
    42. 42
  42. Jaurin, B., T. Grundström, T. Edlund, and S. Normark. 1981. The E. coli ß-lactamase attenuator mediates growth rate-dependent regulation. Nature 290:221–225.[CrossRef][Medline]
    43. 43
  43. Jenks, P. J., Y. M. Hu, F. Danel, S. Mehtar, and D. M. Livermore. 1995. Plasmid-mediated production of class I (AmpC) ß-lactamase by two Klebsiella pneumoniae isolates from the UK. J. Antimicrob. Chemother. 35:235–236.[Free Full Text]
    44. 44
  44. Knothe, H., P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315–317.[CrossRef][Medline]
    45. 45
  45. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type ß-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593–2601.[Medline]
    46. 46
  46. Koeck, J. L., G. Arlet, A. Philippon, S. Basmaciogullari, H. V. Thien, Y. Buisson, and J. D. Cavallo. 1997. A plasmid-mediated CMY-2 ß-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152:255–260.[Medline]
    47. 47
  47. Kuga, A., R. Okamoto, and M. Inoue. 2000. ampR gene mutations that greatly increase class C ß-lactamase activity in Enterobacter cloacae. Antimicrob. Agents Chemother. 44:561–567.[Abstract/Free Full Text]
    48. 48
  48. Levesque, R., P. H. Roy, R. Letarte, and J. C. Pechère. 1982. A plasmid-mediated cephalosporinase from Achromobacter species. J. Infect. Dis. 145:753–761.[Medline]
    49. 49
  49. Livermore, D. M. 1995. ß-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557–584.[Abstract]
    50. 50
  50. Livermore, D. M., and M. Yuan. 1996. Antibiotic resistance and production of extended-spectrum ß-lactamases amongst Klebsiella spp. from intensive care units in Europe. J. Antimicrob. Chemother. 38:409–424.[Abstract/Free Full Text]
    51. 51
  51. Marchese, A., G. Arlet, G. C. Schito, P. H. Lagrange, and A. Philippon. 1998. Characterization of FOX-3, an AmpC-type plasmid-mediated ß-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:464–467.[Abstract/Free Full Text]
    52. 52
  52. Martínez-Martínez, L., M. C. Conejo, A. Pascual, S. Hernández-Allés, S. Ballesta, E. Ramírez De Arellano-Ramos, V. J. Benedí, and E. J. Perea. 2000. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal ß-lactamase and showing altered porin profiles. Antimicrob. Agents Chemother. 44:2534–2536.[Abstract/Free Full Text]
    53. 53
  53. Martínez-Martínez, L., A. Pascual, S. Hernández-Allés, D. Alvarez-Díaz, A. I. Suárez, J. Tran, V. J. Benedí, and G. A. Jacoby. 1999. Roles of ß-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43:1669–1673.[Abstract/Free Full Text]
    54. 54
  54. Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797–799.[CrossRef][Medline]
    55. 55
  55. Maurelli, A. T., R. E. Fernández, C. A. Bloch, C. K. Rode, and A. Fasano. 1998. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. USA 95:3943–3948.[Abstract/Free Full Text]
    56. 56
  56. Medeiros, A. 1997. Evolution and dissemination of ß-lactamases accelerated by generations of ß-lactam antibiotics. Clin. Infect. Dis. 24:S19–S45.
    57. 57
  57. Morosini, M. I., J. A. Ayala, F. Baquero, J. L. Martínez, and J. Blázquez. 2000. Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 44:3137–3143.[Abstract/Free Full Text]
    58. 58
  58. Morosini, M. I., M. C. Negri, B. Shoichet, M. R. Baquero, F. Baquero, and J. Blázquez. 1998. An extended-spectrum AmpC-type ß-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol. Lett. 165:85–90.[Medline]
    59. 59
  59. M’Zali, F. H., J. Heritage, D. M. Gascoyne-Binzi, M. Denton, N. J. Todd, and P. M. Hawkey. 1997. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type ß-lactamase exposed during an outbreak of SHV-5 extended-spectrum ß-lactamase in a Leeds hospital. J. Antimicrob. Chemother. 40:823–831.[Abstract/Free Full Text]
    60. 60
  60. Nadjar, D., M. Rouveau, C. Verdet, J. Donay, J. Herrmann, P. H. Lagrange, A. Philippon, and G. Arlet. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type ß-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol. Lett. 187:35–40.[Medline]
    61. 61
  61. Naumovski, L., J. P. Quinn, D. Miyashiro, M. Patel, K. Bush, S. B. Singer, D. Graves, T. Palzkill, and A. M. Arvin. 1992. Outbreak of ceftazidime resistance due to a novel extended-spectrum ß-lactamase in isolates from cancer patients. Antimicrob. Agents Chemother. 36:1991–1996.[Abstract/Free Full Text]
    62. 62
  62. Nelson, E. C., and B. G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43:957–959.[Abstract/Free Full Text]
    63. 63
  63. Nukaga, M., S. Haruta, K. Tanimoto, K. Kogure, K. Taniguchi, M. Tamaki, and T. Sawai. 1995. Molecular evolution of a class C ß-lactamase extending its substrate specificity. J. Biol. Chem. 270:5729–5735.[Abstract/Free Full Text]
    64. 64
  64. Oefner, C., A. D’Arcy, J. J. Daly, K. Gubernator, R. L. Charnas, I. Heinze, C. Hubschwerlen, and F. K. Winkler. 1990. Refined crystal structure of ß-lactamase from Citrobacter freundii indicates a mechanism for ß-lactam hydrolysis. Nature 343:284–288.[CrossRef][Medline]
    65. 65
  65. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated ß-lactamase (MIR-1) conferring resistance to oxyimino- and {alpha}-methoxy ß-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200–2209.[Abstract/Free Full Text]
    66. 66
  66. Payne, D. J., N. Woodford, and S. G. B. Amyes. 1992. Characterization of the plasmid mediated ß-lactamase BIL-1. J. Antimicrob. Chemother. 30:119–127.[Abstract/Free Full Text]
    67. 67
  67. Philippon, A., G. Arlet, and P. H. Lagrange. 1994. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):17–29.[CrossRef]
    68. 68
  68. Philippon, A., R. Labia, and G. Jacoby. 1989. Extended-spectrum ß-lactamases. Antimicrob. Agents Chemother. 33:1131–1136.[Free Full Text]
    69. 69
  69. Pitout, J. D., K. S. Thomson, N. D. Hanson, A. F. Ehrhardt, E. S. Moland, and C. C. Sanders. 1998. ß-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:1350–1354.[Abstract/Free Full Text]
    70. 70
  70. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769–776.[Abstract/Free Full Text]
    71. 71
  71. Rhimi-Mahjoubi, F., M. Bernier, G. Arlet, Z. Ben Jemaa, P. Jouve, A. Hammami, and A. Philippon. Mise en évidence de la céphalosporinase plasmidique ACC-1 dans différentes entérobactéries (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolées dans un hopital Tunisien (Sfax, 1997–2000). Path. Biol., in press.
    72. 72
  72. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum ß-lactamases at aMassachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193–2199.[Abstract/Free Full Text]
    73. 73
  73. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406–425.[Abstract]
    74. 74
  74. Sanders, C. C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer ß-lactam antibiotics. Annu. Rev. Microbiol. 41:573–593.[CrossRef][Medline]
    75. 75
  75. Sanders, C. C. 1992. ß-lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 14:1089–1099.[Medline]
    76. 76
  76. Sanderson, K. E., A. Hessel, and K. E. Rudd. 1995. Genetic map of Salmonella typhimurium, edition VIII. Microbiol. Rev. 59:241–303.[Abstract/Free Full Text]
    77. 77
  77. Shannon, K. P., A. King, I. Phillips, M. H. Nicolas, and A. Philippon. 1990. Importation of organisms producing broad-spectrum SHV-group ß-lactamases into the United Kingdom. J. Antimicrob. Chemother. 25:343–351.[Abstract/Free Full Text]
    78. 78
  78. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 ß-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206–1210.[Abstract/Free Full Text]
    79. 79
  79. Stokes, H. W., C. Tomaras, Y. Parsons, and R. M. Hall. 1993. The partial 3'-conserved segment duplications in the integrons In6 from pSa and In7 from pDGO100 have a common origin. Plasmid 30:39–50.[CrossRef][Medline]
    80. 80
  80. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum ß-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877–1882.[Abstract/Free Full Text]
    81. 81
  81. Tzouvelekis, L. S., M. Gazouli, E. E. Prinarakis, E. Tzelepi, and N. J. Legakis. 1997. Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48–1220 against ß-lactamases that belong to groups 1, 2b, and 2be. Antimicrob. Agents Chemother. 41:475–477.[Abstract]
    82. 82
  82. Tzouvelekis, L. S., E. Tzelepi, and A. F. Mentis. 1994. Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:2207–2209.[Abstract/Free Full Text]
    83. 83
  83. Tzouvelekis, L. S., E. Tzelepi, A. F. Mentis, and A. Tsakris. 1993. Identification of a novel plasmid-mediated ß-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J. Antimicrob. Chemother. 31:645–654.[Abstract/Free Full Text]
    84. 84
  84. Verdet, C., G. Arlet, G. Barnaud, P. H. Lagrange, and A. Philippon. 2000. A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob. Agents Chemother. 44:222–225.[Abstract/Free Full Text]
    85. 85
  85. Verdet, C., G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterisation of CMY-4, an AmpC-type plasmid-mediated ß-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235–240.[Medline]
    86. 86
  86. Wiedemann, B., H. Dietz, and D. Pfeifle. 1998. Induction of ß-lactamase in Enterobacter cloacae. Clin. Infect. Dis. 27(Suppl. 1):S42–S47.
    87. 87
  87. Winokur, P. L., A. Brueggemann, D. L. DeSalvo, L. Hoffmann, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC ß-lactamase. Antimicrob. Agents Chemother. 44:2777–2783.[Abstract/Free Full Text]
    88. 88
  88. Woodford, N., D. J. Payne, A. P. Johnson, M. J. Weinbren, R. M. Perinpanayagam, R. C. George, B. D. Cookson, and S. G. B. Amyes. 1990. Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli. Lancet 336:253.[Medline]
    89. 89
  89. Wu, S. W., K. Dornbusch, G. Kronvall, and M. Norgren. 1999. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type ß-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC ß-lactamase. Antimicrob. Agents Chemother. 43:1350–1357.[Abstract/Free Full Text]
    90. 90
  90. Wu, S. W., K. Dornbusch, M. Norgren, and G. Kronvall. 1992. Extended spectrum ß-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J. Antimicrob. Chemother. 30:3–16.[Abstract/Free Full Text]
    91. 91
  91. Yan, J.-J., S.-M. Wu, S.-H. Tsai, J.-J. Wu, and I.-J. Su. 2000. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum ß-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob. Agents Chemother. 44:1438–1442.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, January 2002, p. 1-11, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.1-11.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jeong, S. H., Song, W., Kim, J.-S., Kim, H.-S., Lee, K. M. (2009). Broth Microdilution Method To Detect Extended-Spectrum {beta}-Lactamases and AmpC {beta}-Lactamases in Enterobacteriaceae Isolates by Use of Clavulanic Acid and Boronic Acid as Inhibitors. J. Clin. Microbiol. 47: 3409-3412 [Abstract] [Full Text]  
  • Verdet, C., Gautier, V., Chachaty, E., Ronco, E., Hidri, N., Decre, D., Arlet, G. (2009). Genetic Context of Plasmid-Carried blaCMY-2-Like Genes in Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 4002-4006 [Abstract] [Full Text]  
  • Kotsakis, S. D., Papagiannitsis, C. C., Tzelepi, E., Tzouvelekis, L. S., Miriagou, V. (2009). Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase. Antimicrob. Agents Chemother. 53: 3520-3523 [Abstract] [Full Text]  
  • Kohner, P. C., Robberts, F. J. L., Cockerill, F. R. III, Patel, R. (2009). Cephalosporin MIC Distribution of Extended-Spectrum-{beta}-Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species. J. Clin. Microbiol. 47: 2419-2425 [Abstract] [Full Text]  
  • Gonzalez-Lopez, J. J., Coelho, A., Larrosa, M. N., Lavilla, S., Bartolome, R., Prats, G. (2009). First Detection of Plasmid-Encoded blaOXY {beta}-Lactamase. Antimicrob. Agents Chemother. 53: 3143-3146 [Abstract] [Full Text]  
  • Mataseje, L. F., Neumann, N., Crago, B., Baudry, P., Zhanel, G. G., Louie, M., Mulvey, M. R., and the ARO Water Study Group, (2009). Characterization of Cefoxitin-Resistant Escherichia coli Isolates from Recreational Beaches and Private Drinking Water in Canada between 2004 and 2006. Antimicrob. Agents Chemother. 53: 3126-3130 [Abstract] [Full Text]  
  • Doi, Y., Paterson, D. L., Adams-Haduch, J. M., Sidjabat, H. E., O'Keefe, A., Endimiani, A., Bonomo, R. A. (2009). Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 {beta}-Lactamase. Antimicrob. Agents Chemother. 53: 3159-3161 [Abstract] [Full Text]  
  • Baughman, R. P. (2009). The Use of Carbapenems in the Treatment of Serious Infections. J Intensive Care Med 24: 230-241 [Abstract]  
  • Carattoli, A. (2009). Resistance Plasmid Families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 2227-2238 [Full Text]  
  • Daniels, J. B., Call, D. R., Hancock, D., Sischo, W. M., Baker, K., Besser, T. E. (2009). Role of Ceftiofur in Selection and Dissemination of blaCMY-2-Mediated Cephalosporin Resistance in Salmonella enterica and Commensal Escherichia coli Isolates from Cattle. Appl. Environ. Microbiol. 75: 3648-3655 [Abstract] [Full Text]  
  • Zioga, A., Whichard, J. M., Kotsakis, S. D., Tzouvelekis, L. S., Tzelepi, E., Miriagou, V. (2009). CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids. Antimicrob. Agents Chemother. 53: 1256-1259 [Abstract] [Full Text]  
  • Welch, T. J., Evenhuis, J., White, D. G., McDermott, P. F., Harbottle, H., Miller, R. A., Griffin, M., Wise, D. (2009). IncA/C Plasmid-Mediated Florfenicol Resistance in the Catfish Pathogen Edwardsiella ictaluri. Antimicrob. Agents Chemother. 53: 845-846 [Full Text]  
  • Tenover, F. C., Emery, S. L., Spiegel, C. A., Bradford, P. A., Eells, S., Endimiani, A., Bonomo, R. A., McGowan, J. E. Jr. (2009). Identification of Plasmid-Mediated AmpC {beta}-Lactamases in Escherichia coli, Klebsiella spp., and Proteus Species Can Potentially Improve Reporting of Cephalosporin Susceptibility Testing Results. J. Clin. Microbiol. 47: 294-299 [Abstract] [Full Text]  
  • Robberts, F. J. L., Kohner, P. C., Patel, R. (2009). Unreliable Extended-Spectrum {beta}-Lactamase Detection in the Presence of Plasmid-Mediated AmpC in Escherichia coli Clinical Isolates. J. Clin. Microbiol. 47: 358-361 [Abstract] [Full Text]  
  • Song, W., Lee, H., Lee, K., Jeong, S. H., Bae, I. K., Kim, J.-S., Kwak, H.-S. (2009). CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum {beta}-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 58: 261-266 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Yang, H., Chen, H., Yang, Q., Chen, M., Wang, H. (2008). High Prevalence of Plasmid-Mediated Quinolone Resistance Genes qnr and aac(6')-Ib-cr in Clinical Isolates of Enterobacteriaceae from Nine Teaching Hospitals in China. Antimicrob. Agents Chemother. 52: 4268-4273 [Abstract] [Full Text]  
  • Haldorsen, B., Aasnaes, B., Dahl, K. H., Hanssen, A.-M., Simonsen, G. S., Walsh, T. R., Sundsfjord, A., Lundblad, E. W. (2008). The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J Antimicrob Chemother 62: 694-702 [Abstract] [Full Text]  
  • Rosander, A., Connolly, E., Roos, S. (2008). Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L. reuteri DSM 17938. Appl. Environ. Microbiol. 74: 6032-6040 [Abstract] [Full Text]  
  • Hawkey, P. M. (2008). The growing burden of antimicrobial resistance. J Antimicrob Chemother 62: i1-i9 [Abstract] [Full Text]  
  • Empel, J., Baraniak, A., Literacka, E., Mrowka, A., Fiett, J., Sadowy, E., Hryniewicz, W., Gniadkowski, M., and the Beta-PL Study Group, (2008). Molecular Survey of {beta}-Lactamases Conferring Resistance to Newer {beta}-Lactams in Enterobacteriaceae Isolates from Polish Hospitals. Antimicrob. Agents Chemother. 52: 2449-2454 [Abstract] [Full Text]  
  • McIntosh, D., Cunningham, M., Ji, B., Fekete, F. A., Parry, E. M., Clark, S. E., Zalinger, Z. B., Gilg, I. C., Danner, G. R., Johnson, K. A., Beattie, M., Ritchie, R. (2008). Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254. J Antimicrob Chemother 61: 1221-1228 [Abstract] [Full Text]  
  • Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., Nordmann, P. (2008). Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.. Antimicrob. Agents Chemother. 52: 1252-1256 [Abstract] [Full Text]  
  • Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Catry, B., Herman, L., Haesebrouck, F., Butaye, P. (2008). Diversity of Extended-Spectrum {beta}-Lactamases and Class C {beta}-Lactamases among Cloacal Escherichia coli Isolates in Belgian Broiler Farms. Antimicrob. Agents Chemother. 52: 1238-1243 [Abstract] [Full Text]  
  • Li, Y., Li, Q., Du, Y., Jiang, X., Tang, J., Wang, J., Li, G., Jiang, Y. (2008). Prevalence of Plasmid-Mediated AmpC {beta}-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC {beta}-Lactamase Resistance in China. J. Clin. Microbiol. 46: 1317-1321 [Abstract] [Full Text]  
  • Mammeri, H., Eb, F., Berkani, A., Nordmann, P. (2008). Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J Antimicrob Chemother 61: 498-503 [Abstract] [Full Text]  
  • Daniels, J. B., Call, D. R., Besser, T. E. (2007). Molecular Epidemiology of blaCMY-2 Plasmids Carried by Salmonella enterica and Escherichia coli Isolates from Cattle in the Pacific Northwest. Appl. Environ. Microbiol. 73: 8005-8011 [Abstract] [Full Text]  
  • Vimont, S., Aubert, D., Mazoit, J.-X., Poirel, L., Nordmann, P. (2007). Broad-spectrum {beta}-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases. J Antimicrob Chemother 60: 1045-1050 [Abstract] [Full Text]  
  • Papagiannitsis, C. C., Tzouvelekis, L. S., Tzelepi, E., Miriagou, V. (2007). Plasmid-Encoded ACC-4, an Extended-Spectrum Cephalosporinase Variant from Escherichia coli. Antimicrob. Agents Chemother. 51: 3763-3767 [Abstract] [Full Text]  
  • Lee, J., Pai, H., Kim, Y. K., Kim, N. H., Eun, B. W., Kang, H. J., Park, K. H., Choi, E. H., Shin, H. Y., Kim, E. C., Lee, H. J., Ahn, H. S. (2007). Control of extended-spectrum {beta}-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60: 629-637 [Abstract] [Full Text]  
  • Arpin, C., Coulange, L., Dubois, V., Andre, C., Fischer, I., Fourmaux, S., Grobost, F., Jullin, J., Dutilh, B., Couture, J.-F., Noury, P., Lagrange, I., Ducastaing, A., Doermann, H.-P., Quentin, C. (2007). Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae Strains in Various Types of Private Health Care Centers. Antimicrob. Agents Chemother. 51: 3440-3444 [Abstract] [Full Text]  
  • Rello, J. (2007). Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia. ERR 16: 33-39 [Abstract] [Full Text]  
  • Chen, Y.-T., Lauderdale, T.-L., Liao, T.-L., Shiau, Y.-R., Shu, H.-Y., Wu, K.-M., Yan, J.-J., Su, I.-J., Tsai, S.-F. (2007). Sequencing and Comparative Genomic Analysis of pK29, a 269-Kilobase Conjugative Plasmid Encoding CMY-8 and CTX-M-3 {beta}-Lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 51: 3004-3007 [Abstract] [Full Text]  
  • Bell, J. M., Chitsaz, M., Turnidge, J. D., Barton, M., Walters, L. J., Jones, R. N. (2007). Prevalence and Significance of a Negative Extended-Spectrum {beta}-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. J. Clin. Microbiol. 45: 1478-1482 [Abstract] [Full Text]  
  • Glupczynski, Y., Berhin, C., Bauraing, C., Bogaerts, P. (2007). Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae. J. Clin. Microbiol. 45: 501-505 [Abstract] [Full Text]  
  • Doloy, A., Verdet, C., Gautier, V., Decre, D., Ronco, E., Hammami, A., Philippon, A., Arlet, G. (2006). Genetic Environment of Acquired blaACC-1 {beta}-Lactamase Gene in Enterobacteriaceae Isolates. Antimicrob. Agents Chemother. 50: 4177-4181 [Abstract] [Full Text]  
  • Ruppe, E., Bidet, P., Verdet, C., Arlet, G., Bingen, E. (2006). First Detection of the Ambler Class C 1 AmpC {beta}-Lactamase in Citrobacter freundii by a New, Simple Double-Disk Synergy Test. J. Clin. Microbiol. 44: 4204-4207 [Abstract] [Full Text]  
  • Kaczmarek, F. M., Dib-Hajj, F., Shang, W., Gootz, T. D. (2006). High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 {beta}-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE.. Antimicrob. Agents Chemother. 50: 3396-3406 [Abstract] [Full Text]  
  • Spanu, T., Sanguinetti, M., Tumbarello, M., D'Inzeo, T., Fiori, B., Posteraro, B., Santangelo, R., Cauda, R., Fadda, G. (2006). Evaluation of the New VITEK 2 Extended-Spectrum Beta-Lactamase (ESBL) Test for Rapid Detection of ESBL Production in Enterobacteriaceae Isolates.. J. Clin. Microbiol. 44: 3257-3262 [Abstract] [Full Text]  
  • Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., Thomson, K. S. (2006). Prevalence of Newer {beta}-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002.. J. Clin. Microbiol. 44: 3318-3324 [Abstract] [Full Text]  
  • Scheetz, M. H., Hurt, K. M., Noskin, G. A., Oliphant, C. M. (2006). Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.. Am J Health Syst Pharm 63: 1346-1360 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Fortineau, N., Nordmann, P. (2006). Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coli.. Antimicrob. Agents Chemother. 50: 2573-2576 [Abstract] [Full Text]  
  • Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., Kaye, K. S. (2006). Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae.. Antimicrob. Agents Chemother. 50: 1715-1720 [Abstract] [Full Text]  
  • Yan, J.-J., Hsueh, P.-R., Lu, J.-J., Chang, F.-Y., Shyr, J.-M., Wan, J.-H., Liu, Y.-C., Chuang, Y.-C., Yang, Y.-C., Tsao, S.-M., Wu, H.-H., Wang, L.-S., Lin, T.-P., Wu, H.-M., Chen, H.-M., Wu, J.-J. (2006). Extended-Spectrum {beta}-Lactamases and Plasmid-Mediated AmpC Enzymes among Clinical Isolates of Escherichia coli and Klebsiella pneumoniae from Seven Medical Centers in Taiwan.. Antimicrob. Agents Chemother. 50: 1861-1864 [Abstract] [Full Text]  
  • Su, L.-H., Chen, H.-L., Chia, J.-H., Liu, S.-Y., Chu, C., Wu, T.-L., Chiu, C.-H. (2006). Distribution of a transposon-like element carrying blaCMY-2 among Salmonella and other Enterobacteriaceae. J Antimicrob Chemother 57: 424-429 [Abstract] [Full Text]  
  • Wachino, J.-i., Kurokawa, H., Suzuki, S., Yamane, K., Shibata, N., Kimura, K., Ike, Y., Arakawa, Y. (2006). Horizontal Transfer of blaCMY-Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50: 534-541 [Abstract] [Full Text]  
  • Verdet, C., Benzerara, Y., Gautier, V., Adam, O., Ould-Hocine, Z., Arlet, G. (2006). Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii. Antimicrob. Agents Chemother. 50: 607-617 [Abstract] [Full Text]  
  • D'Andrea, M. M., Nucleo, E., Luzzaro, F., Giani, T., Migliavacca, R., Vailati, F., Kroumova, V., Pagani, L., Rossolini, G. M. (2006). CMY-16, a Novel Acquired AmpC-Type {beta}-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy. Antimicrob. Agents Chemother. 50: 618-624 [Abstract] [Full Text]  
  • Brinas, L., Lantero, M., de Diego, I., Alvarez, M., Zarazaga, M., Torres, C. (2005). Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 56: 1107-1110 [Abstract] [Full Text]  
  • Alba, J., Ishii, Y., Thomson, K., Moland, E. S., Yamaguchi, K. (2005). Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother. 49: 4760-4762 [Abstract] [Full Text]  
  • Bauvois, C., Ibuka, A. S., Celso, A., Alba, J., Ishii, Y., Frere, J.-M., Galleni, M. (2005). Kinetic Properties of Four Plasmid-Mediated AmpC {beta}-Lactamases. Antimicrob. Agents Chemother. 49: 4240-4246 [Abstract] [Full Text]  
  • Song, W., Moland, E. S., Hanson, N. D., Lewis, J. S., Jorgensen, J. H., Thomson, K. S. (2005). Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia. J. Clin. Microbiol. 43: 4891-4894 [Abstract] [Full Text]  
  • Pichardo, C., Rodriguez-Martinez, J. M., Pachon-Ibanez, M. E., Conejo, C., Ibanez-Martinez, J., Martinez-Martinez, L., Pachon, J., Pascual, A. (2005). Efficacy of Cefepime and Imipenem in Experimental Murine Pneumonia Caused by Porin-Deficient Klebsiella pneumoniae Producing CMY-2 {beta}-Lactamase. Antimicrob. Agents Chemother. 49: 3311-3316 [Abstract] [Full Text]  
  • Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., Nordmann, P. (2005). Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA. Antimicrob. Agents Chemother. 49: 3523-3525 [Abstract] [Full Text]  
  • Bidet, P., Burghoffer, B., Gautier, V., Brahimi, N., Mariani-Kurkdjian, P., El-Ghoneimi, A., Bingen, E., Arlet, G. (2005). In Vivo Transfer of Plasmid-Encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an Infant and Selection of Impermeability to Imipenem in K. pneumoniae. Antimicrob. Agents Chemother. 49: 3562-3565 [Abstract] [Full Text]  
  • Coudron, P. E. (2005). Inhibitor-Based Methods for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J. Clin. Microbiol. 43: 4163-4167 [Abstract] [Full Text]  
  • Black, J. A., Moland, E. S., Thomson, K. S. (2005). AmpC Disk Test for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC {beta}-Lactamases. J. Clin. Microbiol. 43: 3110-3113 [Abstract] [Full Text]  
  • Politi, L., Tassios, P. T., Lambiri, M., Kansouzidou, A., Pasiotou, M., Vatopoulos, A. C., Mellou, K., Legakis, N. J., Tzouvelekis, L. S. (2005). Repeated Occurrence of Diverse Extended-Spectrum {beta}-Lactamases in Minor Serotypes of Food-Borne Salmonella enterica subsp. enterica. J. Clin. Microbiol. 43: 3453-3456 [Abstract] [Full Text]  
  • Yagi, T., Wachino, J.-i., Kurokawa, H., Suzuki, S., Yamane, K., Doi, Y., Shibata, N., Kato, H., Shibayama, K., Arakawa, Y. (2005). Practical Methods Using Boronic Acid Compounds for Identification of Class C {beta}-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 43: 2551-2558 [Abstract] [Full Text]  
  • Kaneko, K., Okamoto, R., Nakano, R., Kawakami, S., Inoue, M. (2005). Gene Mutations Responsible for Overexpression of AmpC {beta}-Lactamase in Some Clinical Isolates of Enterobacter cloacae. J. Clin. Microbiol. 43: 2955-2958 [Abstract] [Full Text]  
  • Ohana, S., Leflon, V., Ronco, E., Rottman, M., Guillemot, D., Lortat-Jacob, S., Denys, P., Loubert, G., Nicolas-Chanoine, M.-H., Gaillard, J.-L., Lawrence, C. (2005). Spread of a Klebsiella pneumoniae Strain Producing a Plasmid- Mediated ACC-1 AmpC {beta}-Lactamase in a Teaching Hospital Admitting Disabled Patients. Antimicrob. Agents Chemother. 49: 2095-2097 [Abstract] [Full Text]  
  • Bert, F., Juvin, M., Ould-Hocine, Z., Clarebout, G., Keller, E., Lambert, N., Arlet, G. (2005). Evaluation and Updating of the Osiris Expert System for Identification of Escherichia coli {beta}-Lactam Resistance Phenotypes. J. Clin. Microbiol. 43: 1846-1850 [Abstract] [Full Text]  
  • Brinas, L., Moreno, M. A., Teshager, T., Saenz, Y., Porrero, M. C., Dominguez, L., Torres, C. (2005). Monitoring and Characterization of Extended-Spectrum {beta}-Lactamases in Escherichia coli Strains from Healthy and Sick Animals in Spain in 2003. Antimicrob. Agents Chemother. 49: 1262-1264 [Abstract] [Full Text]  
  • (2005). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am. J. Respir. Crit. Care Med. 171: 388-416 [Full Text]  
  • Miro, E., Mirelis, B., Navarro, F., Matas, L., Gimenez, M., Rabaza, C. (2005). Escherichia coli Producing an ACC-1 Class C {beta}-Lactamase Isolated in Barcelona, Spain. Antimicrob. Agents Chemother. 49: 866-867 [Full Text]  
  • Jacoby, G. A., Munoz-Price, L. S. (2005). The New {beta}-Lactamases. NEJM 352: 380-391 [Full Text]  
  • Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E., Paton, S., the Canadian Hospital Epidemiology Committee, , the Canadian Nosocomial Infection Surveillance Pro, (2005). Molecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals. Antimicrob. Agents Chemother. 49: 358-365 [Abstract] [Full Text]  
  • Kang, C.-I., Pai, H., Kim, S.-H., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W. (2004). Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type {beta}-lactamase. J Antimicrob Chemother 54: 1130-1133 [Abstract] [Full Text]  
  • Literacka, E., Empel, J., Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M. (2004). Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland. Antimicrob. Agents Chemother. 48: 4136-4143 [Abstract] [Full Text]  
  • Liebana, E., Batchelor, M., Clifton-Hadley, F. A., Davies, R. H., Hopkins, K. L., Threlfall, E. J. (2004). First Report of Salmonella Isolates with the DHA-1 AmpC {beta}-Lactamase in the United Kingdom. Antimicrob. Agents Chemother. 48: 4492-4492 [Full Text]  
  • Yan, J.-J., Ko, W.-C., Wu, H.-M., Tsai, S.-H., Chuang, C.-L., Wu, J.-J. (2004). Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan. J. Clin. Microbiol. 42: 5337-5340 [Abstract] [Full Text]  
  • Sturenburg, E., Lang, M., Horstkotte, M. A., Laufs, R., Mack, D. (2004). Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum {beta}-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. J Antimicrob Chemother 54: 870-875 [Abstract] [Full Text]  
  • Pai, H., Kang, C.-I., Byeon, J.-H., Lee, K.-D., Park, W. B., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W. (2004). Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-{beta}-Lactamase-Producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48: 3720-3728 [Abstract] [Full Text]  
  • Mammeri, H., Nazic, H., Naas, T., Poirel, L., Leotard, S., Nordmann, P. (2004). AmpC {beta}-Lactamase in an Escherichia coli Clinical Isolate Confers Resistance to Expanded-Spectrum Cephalosporins. Antimicrob. Agents Chemother. 48: 4050-4053 [Abstract] [Full Text]  
  • Nasim, K., Elsayed, S., Pitout, J. D. D., Conly, J., Church, D. L., Gregson, D. B. (2004). New Method for Laboratory Detection of AmpC {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae. J. Clin. Microbiol. 42: 4799-4802 [Abstract] [Full Text]  
  • Wachino, J.-i., Doi, Y., Yamane, K., Shibata, N., Yagi, T., Kubota, T., Arakawa, Y. (2004). Molecular Characterization of a Cephamycin-Hydrolyzing and Inhibitor-Resistant Class A {beta}-Lactamase, GES-4, Possessing a Single G170S Substitution in the {Omega}-Loop. Antimicrob. Agents Chemother. 48: 2905-2910 [Abstract] [Full Text]  
  • Miriagou, V., Tzouvelekis, L. S., Villa, L., Lebessi, E., Vatopoulos, A. C., Carattoli, A., Tzelepi, E. (2004). CMY-13, a Novel Inducible Cephalosporinase Encoded by an Escherichia coli Plasmid. Antimicrob. Agents Chemother. 48: 3172-3174 [Abstract] [Full Text]  
  • Poirel, L., Heritier, C., Spicq, C., Nordmann, P. (2004). In Vivo Acquisition of High-Level Resistance to Imipenem in Escherichia coli. J. Clin. Microbiol. 42: 3831-3833 [Abstract] [Full Text]  
  • Bonnefoy, A., Dupuis-Hamelin, C., Steier, V., Delachaume, C., Seys, C., Stachyra, T., Fairley, M., Guitton, M., Lampilas, M. (2004). In vitro activity of AVE1330A, an innovative broad-spectrum non-{beta}-lactam {beta}-lactamase inhibitor. J Antimicrob Chemother 54: 410-417 [Abstract] [Full Text]  
  • Yan, J.-J., Ko, W.-C., Wu, J.-J., Tsai, S.-H., Chuang, C.-L. (2004). Epidemiological Investigation of Bloodstream Infections by Extended Spectrum Cephalosporin-Resistant Escherichia coli in a Taiwanese Teaching Hospital. J. Clin. Microbiol. 42: 3329-3332 [Abstract] [Full Text]  
  • Sturenburg, E., Sobottka, I., Noor, D., Laufs, R., Mack, D. (2004). Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum {beta}-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 54: 134-138 [Abstract] [Full Text]  
  • Hossain, A., Reisbig, M. D., Hanson, N. D. (2004). Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium. J Antimicrob Chemother 53: 964-970 [Abstract] [Full Text]  
  • Black, J. A., Thomson, K. S., Pitout, J. D. D. (2004). Use of {beta}-Lactamase Inhibitors in Disk Tests To Detect Plasmid-Mediated AmpC {beta}-Lactamases. J. Clin. Microbiol. 42: 2203-2206 [Abstract] [Full Text]  
  • Nakano, R., Okamoto, R., Nakano, Y., Kaneko, K., Okitsu, N., Hosaka, Y., Inoue, M. (2004). CFE-1, a Novel Plasmid-Encoded AmpC {beta}-Lactamase with an ampR Gene Originating from Citrobacter freundii. Antimicrob. Agents Chemother. 48: 1151-1158 [Abstract] [Full Text]  
  • Yan, J.-J., Hong, C.-Y., Ko, W.-C., Chen, Y.-J., Tsai, S.-H., Chuang, C.-L., Wu, J.-J. (2004). Dissemination of blaCMY-2 among Escherichia coli Isolates from Food Animals, Retail Ground Meats, and Humans in Southern Taiwan. Antimicrob. Agents Chemother. 48: 1353-1356 [Abstract] [Full Text]  
  • Betancor, L., Schelotto, F., Martinez, A., Pereira, M., Algorta, G., Rodriguez, M. A., Vignoli, R., Chabalgoity, J. A. (2004). Random Amplified Polymorphic DNA and Phenotyping Analysis of Salmonella enterica Serovar Enteritidis Isolates Collected from Humans and Poultry in Uruguay from 1995 to 2002. J. Clin. Microbiol. 42: 1155-1162 [Abstract] [Full Text]  
  • Alvarez, M., Tran, J. H., Chow, N., Jacoby, G. A. (2004). Epidemiology of Conjugative Plasmid-Mediated AmpC {beta}-Lactamases in the United States. Antimicrob. Agents Chemother. 48: 533-537 [Abstract] [Full Text]  
  • Bonnet, R. (2004). Growing Group of Extended-Spectrum {beta}-Lactamases: the CTX-M Enzymes. Antimicrob. Agents Chemother. 48: 1-14 [Full Text]  
  • Poirel, L., Heritier, C., Tolun, V., Nordmann, P. (2004). Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48: 15-22 [Abstract] [Full Text]  
  • Nikaido, H. (2003). Molecular Basis of Bacterial Outer Membrane Permeability Revisited. Microbiol. Mol. Biol. Rev. 67: 593-656 [Abstract] [Full Text]  
  • Pitout, J. D. D., Reisbig, M. D., Mulvey, M., Chui, L., Louie, M., Crowe, L., Church, D. L., Elsayed, S., Gregson, D., Ahmed, R., Tilley, P., Hanson, N. D. (2003). Association between Handling of Pet Treats and Infection with Salmonella enterica Serotype Newport Expressing the AmpC {beta}-Lactamase, CMY-2. J. Clin. Microbiol. 41: 4578-4582 [Abstract] [Full Text]  
  • Rodriguez-Martinez, J. M., Pascual, A., Garcia, I., Martinez-Martinez, L. (2003). Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type {beta}-lactamase. J Antimicrob Chemother 52: 703-706 [Abstract] [Full Text]  
  • De Gheldre, Y., Avesani, V., Berhin, C., Delmee, M., Glupczynski, Y. (2003). Evaluation of Oxoid combination discs for detection of extended-spectrum {beta}-lactamases. J Antimicrob Chemother 52: 591-597 [Abstract] [Full Text]  
  • Preston, K. E., Graffunder, E. M., Evans, A. M., Venezia, R. A. (2003). Survey of Plasmid-Associated Genetic Markers in Enterobacteriaceae with Reduced Susceptibilities to Cephalosporins. Antimicrob. Agents Chemother. 47: 2179-2185 [Abstract] [Full Text]  
  • Makanera, A., Arlet, G., Gautier, V., Manai, M. (2003). Molecular Epidemiology and Characterization of Plasmid-Encoded {beta}-Lactamases Produced by Tunisian Clinical Isolates of Salmonella enterica Serotype Mbandaka Resistant to Broad-Spectrum Cephalosporins. J. Clin. Microbiol. 41: 2940-2945 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philippon, A.
Right arrow Articles by Jacoby, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philippon, A.
Right arrow Articles by Jacoby, G. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»